Patients tend to ask which drug has fewer side effects, but the better question is often which side-effect profile is more predictable
Lucrative weight loss drugs are new focus for diabetes patients The insulin supply shortages come as diabetes patients increasingly turn to drugs such as Ozempic and Mounjaro, part of a new category of weight loss medication called glucagon-like peptide 1, or GLP-1 drugs, which are approved to treat Type 2 diabetes
The company said its facilities integrate advanced pharmacy capabilities, lab testing and R&D space
sciencedirect PubMed review: Implications of GLP-1 Agonists on Office-Based Sedation and General Anesthesia pubmed.ncbi.nlm.nih ASA Consensus-Based Guidance on Preoperative Management of Patients on GLP-1s pubmed.ncbi.nlm.nih Similar posts
expect dose-escalation dips to resolve GI distress generally B-Complex
The delayed gastric emptying characteristic of these therapies frequently causes gastrointestinal adverse effects, particularly nausea, vomiting, and diarrhea
